Samumed
Toggle navigation
Home
Company
Patients
Team
Technology
Pipeline
Publications
Media
SAMUMED NEWS
VIEW ALL
Samumed's Osteoarthritis Research Selected for an Oral Presentation at a Gordon Research Conference
Learn More
Samumed Successfully Completed 52-week Phase 2 Study for Treatment of Osteoarthritis of the Knee
Learn More
Samumed Receives Orphan Drug Designation from FDA for SM04646 as a Treatment for Idiopathic Pulmonary Fibrosis (IPF)
Learn More
ABOUT SAMUMED
Pipeline
Publications
Company
Team
Technology
×
The Wnt Pathway
Your browser does not support HTML5 video.